Compare BNTC & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | FTW |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.4M | 470.2M |
| IPO Year | 2020 | 2024 |
| Metric | BNTC | FTW |
|---|---|---|
| Price | $11.04 | $12.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | ★ 168.2K | 77.9K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $9.50 |
| 52 Week High | $17.15 | $17.20 |
| Indicator | BNTC | FTW |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 57.55 |
| Support Level | $10.10 | $9.50 |
| Resistance Level | $13.06 | $17.20 |
| Average True Range (ATR) | 0.79 | 1.75 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 30.21 | 43.77 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
EQV Ventures Acquisition Corp is a blank check company.